Figure 1From: Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumorsPromoter hypermethylation in patients with sensitive and resistant GCTs in response to cisplatin combination chemotherapy. RASSF1A and HIC1 genes showed frequent methylation in resistant tumors, while MGMT and RARB promoters were more commonly methylated in sensitive tumors.Back to article page